These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17409892)

  • 41. Adenocarcinoma with epidermal growth factor receptor gene mutations in three siblings.
    Sakakibara T; Saijo Y; Fukuhara T; Gomi K; Inoue A; Ishimoto O; Sugawara S; Nukiwa T
    J Thorac Oncol; 2008 Mar; 3(3):311-3. PubMed ID: 18317075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor receptor mutations in 510 Finnish non--small-cell lung cancer patients.
    Mäki-Nevala S; Rönty M; Morel M; Gomez M; Dawson Z; Sarhadi VK; Telaranta-Keerie A; Knuuttila A; Knuutila S
    J Thorac Oncol; 2014 Jun; 9(6):886-91. PubMed ID: 24828666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EGFR mutation and lobar location of lung adenocarcinoma.
    Tseng CH; Chen KC; Hsu KH; Tseng JS; Ho CC; Hsia TC; Su KY; Wu MF; Chiu KL; Liu CM; Wu TC; Chen HJ; Chen HY; Chang CS; Hsu CP; Hsia JY; Chuang CY; Lin CH; Chen JJW; Chen KY; Liao WY; Shih JY; Yu SL; Yu CJ; Yang PC; Yang TY; Chang GC
    Carcinogenesis; 2016 Feb; 37(2):157-162. PubMed ID: 26645716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency and type of epidermal growth factor receptor mutations in moroccan patients with lung adenocarcinoma.
    Errihani H; Inrhaoun H; Boukir A; Kettani F; Gamra L; Mestari A; Jabri L; Bensouda Y; Mrabti H; Elghissassi I
    J Thorac Oncol; 2013 Sep; 8(9):1212-4. PubMed ID: 23945389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients.
    Liam CK; Wahid MI; Rajadurai P; Cheah YK; Ng TS
    J Thorac Oncol; 2013 Jun; 8(6):766-72. PubMed ID: 23575413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
    Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
    Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer.
    Hsieh RK; Lim KH; Kuo HT; Tzen CY; Huang MJ
    Chest; 2005 Jul; 128(1):317-21. PubMed ID: 16002952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Diagnostic Value of Quantitative CT Analysis of Ground-Glass Volume Percentage in Differentiating Epidermal Growth Factor Receptor Mutation and Subtypes in Lung Adenocarcinoma.
    Wang H; Guo H; Wang Z; Shan B; Lin J
    Biomed Res Int; 2019; 2019():9643836. PubMed ID: 30956990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.
    Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequency of Epidermal Growth Factor Receptor Mutation in Smokers with Lung Cancer Without Pulmonary Emphysema.
    Takeda K; Yamasaki A; Igishi T; Kawasaki Y; Ito-Nishii S; Izumi H; Sakamoto T; Touge H; Kodani M; Makino H; Yanai M; Tanaka N; Matsumoto S; Araki K; Nakamura H; Shimizu E
    Anticancer Res; 2017 Feb; 37(2):765-771. PubMed ID: 28179328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EGFR and erbB2 mutation status in Japanese lung cancer patients.
    Sasaki H; Shimizu S; Endo K; Takada M; Kawahara M; Tanaka H; Matsumura A; Iuchi K; Haneda H; Suzuki E; Kobayashi Y; Yano M; Fujii Y
    Int J Cancer; 2006 Jan; 118(1):180-4. PubMed ID: 16003726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.
    Riely GJ; Pao W; Pham D; Li AR; Rizvi N; Venkatraman ES; Zakowski MF; Kris MG; Ladanyi M; Miller VA
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):839-44. PubMed ID: 16467097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
    Kozuki T; Hisamoto A; Tabata M; Takigawa N; Kiura K; Segawa Y; Nakata M; Mandai K; Eguchi K; Ueoka H; Tanimoto M
    Lung Cancer; 2007 Oct; 58(1):30-5. PubMed ID: 17561305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complex mutations in the epidermal growth factor receptor gene in non-small cell lung cancer.
    Hata A; Yoshioka H; Fujita S; Kunimasa K; Kaji R; Imai Y; Tomii K; Iwasaku M; Nishiyama A; Ishida T; Katakami N
    J Thorac Oncol; 2010 Oct; 5(10):1524-8. PubMed ID: 20808254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effective mutation of epidermal growth factor receptor in synchronous multiple primary lung cancers: study of clinical, radiographic and pathological factors].
    Wang YJ; Feng H; Ma SR; Wang YC; Liu YY; Bai HJ; Zhao L
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(29):2297-2301. PubMed ID: 31434406
    [No Abstract]   [Full Text] [Related]  

  • 56. Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Togashi Y; Masago K; Kubo T; Sakamori Y; Kim YH; Hatachi Y; Fukuhara A; Mio T; Togashi K; Mishima M
    Cancer; 2011 Feb; 117(4):819-25. PubMed ID: 20886633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
    Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlations of thin-section computed tomographic, histopathological, and clinical findings of adenocarcinoma with a bubblelike appearance.
    Kojima Y; Saito H; Sakuma Y; Kondo T; Ito H; Tsuboi M; Oshita F; Nakayama H; Yokose T; Kameda Y; Noda K; Yamada K
    J Comput Assist Tomogr; 2010; 34(3):413-7. PubMed ID: 20498546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival.
    Aoki T; Tomoda Y; Watanabe H; Nakata H; Kasai T; Hashimoto H; Kodate M; Osaki T; Yasumoto K
    Radiology; 2001 Sep; 220(3):803-9. PubMed ID: 11526285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis.
    Cheng Z; Shan F; Yang Y; Shi Y; Zhang Z
    BMC Med Imaging; 2017 Jan; 17(1):5. PubMed ID: 28068946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.